248 related articles for article (PubMed ID: 11600396)
1. Eradication of biofilm-forming Staphylococcus epidermidis (RP62A) by a combination of sodium salicylate and vancomycin.
Polonio RE; Mermel LA; Paquette GE; Sperry JF
Antimicrob Agents Chemother; 2001 Nov; 45(11):3262-6. PubMed ID: 11600396
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of icaA, atlE and aap genes by linezolid but not vancomycin in Staphylococcus epidermidis RP62A biofilms.
Reiter KC; Sant'Anna FH; d'Azevedo PA
Int J Antimicrob Agents; 2014 Mar; 43(3):248-53. PubMed ID: 24389080
[TBL] [Abstract][Full Text] [Related]
3. Low concentrations of vancomycin stimulate biofilm formation in some clinical isolates of Staphylococcus epidermidis.
Cargill JS; Upton M
J Clin Pathol; 2009 Dec; 62(12):1112-6. PubMed ID: 19640858
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of alpha-mangostin in killing and eradicating Staphylococcus epidermidis RP62A biofilms.
Sivaranjani M; Prakash M; Gowrishankar S; Rathna J; Pandian SK; Ravi AV
Appl Microbiol Biotechnol; 2017 Apr; 101(8):3349-3359. PubMed ID: 28343241
[TBL] [Abstract][Full Text] [Related]
5. Synergy between protamine and vancomycin in the treatment of Staphylococcus epidermidis biofilms.
Lee CK; Rubin LG; Moldwin RM
Urology; 1995 Apr; 45(4):720-4. PubMed ID: 7716861
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial activities of YycG histidine kinase inhibitors against Staphylococcus epidermidis biofilms.
Qin Z; Lee B; Yang L; Zhang J; Yang X; Qu D; Jiang H; Molin S
FEMS Microbiol Lett; 2007 Aug; 273(2):149-56. PubMed ID: 17578527
[TBL] [Abstract][Full Text] [Related]
7. Synergy of ultrasound microbubbles and vancomycin against Staphylococcus epidermidis biofilm.
Dong Y; Chen S; Wang Z; Peng N; Yu J
J Antimicrob Chemother; 2013 Apr; 68(4):816-26. PubMed ID: 23248238
[TBL] [Abstract][Full Text] [Related]
8. MRT letter: Spatial distribution of vancomycin-induced damage in Staphylococcus epidermidis biofilm: an electron microscopic study.
Singh R; Ray P; Das A; Sharma M
Microsc Res Tech; 2010 Jul; 73(7):662-4. PubMed ID: 20572203
[TBL] [Abstract][Full Text] [Related]
9. Evidence for persisters in Staphylococcus epidermidis RP62a planktonic cultures and biofilms.
Shapiro JA; Nguyen VL; Chamberlain NR
J Med Microbiol; 2011 Jul; 60(Pt 7):950-960. PubMed ID: 21415203
[TBL] [Abstract][Full Text] [Related]
10. Inefficacy of vancomycin and teicoplanin in eradicating and killing Staphylococcus epidermidis biofilms in vitro.
Claessens J; Roriz M; Merckx R; Baatsen P; Van Mellaert L; Van Eldere J
Int J Antimicrob Agents; 2015 Apr; 45(4):368-75. PubMed ID: 25614358
[TBL] [Abstract][Full Text] [Related]
11. Application of a feasible method for determination of biofilm antimicrobial susceptibility in staphylococci.
Antunes AL; Trentin DS; Bonfanti JW; Pinto CC; Perez LR; Macedo AJ; Barth AL
APMIS; 2010 Nov; 118(11):873-7. PubMed ID: 20955460
[TBL] [Abstract][Full Text] [Related]
12. Confocal laser scanning microscopy analysis of S. epidermidis biofilms exposed to farnesol, vancomycin and rifampicin.
Cerca N; Gomes F; Pereira S; Teixeira P; Oliveira R
BMC Res Notes; 2012 May; 5():244. PubMed ID: 22591918
[TBL] [Abstract][Full Text] [Related]
13. Staphylococcus epidermidis biofilms control by N-acetylcysteine and rifampicin.
Leite B; Gomes F; Teixeira P; Souza C; Pizzolitto E; Oliveira R
Am J Ther; 2013; 20(4):322-8. PubMed ID: 21519220
[TBL] [Abstract][Full Text] [Related]
14. A dynamic in vitro model for evaluating antimicrobial activity against bacterial biofilms using a new device and clinical-used catheters.
García I; Conejo Mdel C; Ojeda A; Rodríguez-Baño J; Pascual A
J Microbiol Methods; 2010 Dec; 83(3):307-11. PubMed ID: 20888868
[TBL] [Abstract][Full Text] [Related]
15. In vitro activities of telavancin and vancomycin against biofilm-producing Staphylococcus aureus, S. epidermidis, and Enterococcus faecalis strains.
LaPlante KL; Mermel LA
Antimicrob Agents Chemother; 2009 Jul; 53(7):3166-9. PubMed ID: 19451302
[TBL] [Abstract][Full Text] [Related]
16. High in vitro antimicrobial activity of β-peptoid-peptide hybrid oligomers against planktonic and biofilm cultures of Staphylococcus epidermidis.
Liu Y; Knapp KM; Yang L; Molin S; Franzyk H; Folkesson A
Int J Antimicrob Agents; 2013 Jan; 41(1):20-7. PubMed ID: 23153961
[TBL] [Abstract][Full Text] [Related]
17. High-throughput screening for small-molecule inhibitors of Staphylococcus epidermidis RP62a biofilms.
Panmanee W; Taylor D; Shea CJ; Tang H; Nelson S; Seibel W; Papoian R; Kramer R; Hassett DJ; Lamkin TJ
J Biomol Screen; 2013 Aug; 18(7):820-9. PubMed ID: 23543429
[TBL] [Abstract][Full Text] [Related]
18. Activity of bone cement loaded with daptomycin alone or in combination with gentamicin or PEG600 against Staphylococcus epidermidis biofilms.
Peñalba Arias P; Furustrand Tafin U; Bétrisey B; Vogt S; Trampuz A; Borens O
Injury; 2015 Feb; 46(2):249-53. PubMed ID: 25498330
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobials as potential adjunctive agents in the treatment of biofilm infection with Staphylococcus epidermidis.
Peck KR; Kim SW; Jung SI; Kim YS; Oh WS; Lee JY; Jin JH; Kim S; Song JH; Kobayashi H
Chemotherapy; 2003 Jul; 49(4):189-93. PubMed ID: 12886054
[TBL] [Abstract][Full Text] [Related]
20. Pentadecanal inspired molecules as new anti-biofilm agents against Staphylococcus epidermidis.
Ricciardelli A; Casillo A; Papa R; Monti DM; Imbimbo P; Vrenna G; Artini M; Selan L; Corsaro MM; Tutino ML; Parrilli E
Biofouling; 2018 Nov; 34(10):1110-1120. PubMed ID: 30698031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
